Difference between revisions of "Sasaki H, et al. Development (1999) cited as Ref 216 in DOI: 10.1038/s41392-020-0110-5 (Q9479)"
Jump to navigation
Jump to search
(Created claim: Page(s) (P105): 3915-3924, #quickstatements; #temporary_batch_1590074839150) |
(Created claim: Fourth Author string (P152): Nakafuku M, #quickstatements; #temporary_batch_1590155310798) |
||
| Property / Fourth Author string | |||
| + | Nakafuku M | ||
| Property / Fourth Author string: Nakafuku M / rank | |||
| + | Normal rank | ||
Revision as of 13:49, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Sasaki H, et al. Development (1999) cited as Ref 216 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Sasaki H
0 references
Nishizaki Y
0 references
Hui C
0 references
1999
0 references
Development
0 references
126
0 references
Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling (English)
0 references
3915-3924
0 references
Nakafuku M
0 references
